Publicação
The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity
| dc.contributor.author | Salústio, Paulo | |
| dc.contributor.author | Feio, Gabriel | |
| dc.contributor.author | Figueirinhas, João | |
| dc.contributor.author | Pinto, João | |
| dc.contributor.author | Marques, Helena | |
| dc.date.accessioned | 2011-07-22T12:26:25Z | |
| dc.date.available | 2011-07-22T12:26:25Z | |
| dc.date.issued | 2008-10-17 | |
| dc.description | NOTICE: this is the author’s version of a work that was accepted for publication in European Journal of Pharmaceutics and Biopharmaceutics. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Eur J Pharm Biopharm. 2009 Feb;71(2):377-386. Epub 2008 Oct 17. | |
| dc.description.abstract | The work aims to prove the complexation of two model drugs (ibuprofen, IB and indomethacin, IN) by bcyclodextrin (bCD), and the effect of water in such a process, and makes a comparison of their complexation yields. Two methods were considered: kneading of a binary mixture of the drug, bCD, and inclusion of either IB or IN in aqueous solutions of bCD. In the latter method water was removed by air stream, spray-drying and freeze-drying. To prove the formation of complexes in final products, optical microscopy, UV spectroscopy, IR spectroscopy, DSC, X-ray and NMR were considered. Each powder was added to an acidic solution (pH = 2) to quantify the concentration of the drug inside bCD cavity. Other media (pH = 5 and 7) were used to prove the existence of drug not complexed in each powder, as the drugs solubility increases with the pH. It was observed that complexation occurred in all powders, and that the fraction of drug inside the bCD did not depend neither on the method of complexation nor on the processes of drying considered. | por |
| dc.identifier.citation | Eur J Pharm Biopharm. 2009 Feb; 71(2):377-386 | por |
| dc.identifier.issn | 0939-6411 | |
| dc.identifier.uri | http://hdl.handle.net/10451/3805 | |
| dc.identifier.uri | http://dx.doi.org/10.1016/j.ejpb.2008.09.027 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Elsevier | |
| dc.subject | Ibuprofen | por |
| dc.subject | Indomethacin | por |
| dc.subject | Cyclodextrin | por |
| dc.subject | Freeze-drying | por |
| dc.subject | Spray-drying | por |
| dc.subject | Physical mixture | por |
| dc.subject | Kneading | por |
| dc.subject | NMR | por |
| dc.subject | X-ray | por |
| dc.subject | Optical microscopy | por |
| dc.subject | FT-IR spectroscopy | por |
| dc.subject | UV spectroscopy | por |
| dc.subject | DSC | por |
| dc.title | The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 386 | por |
| oaire.citation.startPage | 377 | por |
| oaire.citation.title | European Journal of Pharmaceutics and Biopharmaceutics | por |
| person.familyName | Marques | |
| person.givenName | Helena | |
| person.identifier.ciencia-id | DB1F-B511-D3F2 | |
| person.identifier.orcid | 0000-0002-9255-4697 | |
| person.identifier.rid | A-9739-2014 | |
| person.identifier.scopus-author-id | 6603071227 | |
| rcaap.rights | openAccess | por |
| rcaap.type | article | por |
| relation.isAuthorOfPublication | b30c4f1a-38da-49ed-bfa7-24e6eb08f072 | |
| relation.isAuthorOfPublication.latestForDiscovery | b30c4f1a-38da-49ed-bfa7-24e6eb08f072 |